Rivastigmine Good Manufacturer supply High Quality 123441-03-2
- Molecular Formula:C14H22N2O2
- Molecular Weight:400.429
- Vapor Pressure:0.000416mmHg at 25°C
- Refractive Index:1.518
- Boiling Point:316.2 °C at 760 mmHg
- PKA:pKa 8.99 (Uncertain)
- Flash Point:145 °C
- PSA：147.84000
- Density:1.038 g/cm3
- LogP:0.63710
Rivastigmine (123441-03-2) Usage
Rivastigmine, also known as Exelon, is a pseudoirreversible noncompetitive carbamate inhibitor of acetylcholinesterase (AChE). It is a carbamate ester obtained by formal condensation of the carboxy group of ethyl(methyl)carbamic acid with the phenolic OH group of 3-[(1S)-1-(dimethylamino)ethyl]phenol. Rivastigmine has a half-life of approximately 2 hours, but its inhibitory properties last for up to 10 hours due to the slow dissociation of the drug from the enzyme. The Food and Drug Administration (FDA) approved its use in mild-to-moderate Alzheimer's disease in April 2000 and for managing mild-to-moderate dementia associated with Parkinson's disease in July 2007.
How to get the best price on Rivastigmine?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Rivastigmine . You can buy high quality, low price Rivastigmine 123441-03-2 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
